{"id":326995,"date":"2026-10-26T16:42:50","date_gmt":"2026-10-26T11:12:50","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=326995"},"modified":"2026-10-26T16:42:50","modified_gmt":"2026-10-26T11:12:50","slug":"active-ingredients-and-custom-manufacturing-company-excipients-and-nutrition-ingredients-maker-and-portable-molecular-testing-firm-stocks-roadmap-horizon-list","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/active-ingredients-and-custom-manufacturing-company-excipients-and-nutrition-ingredients-maker-and-portable-molecular-testing-firm-stocks-roadmap-horizon-list\/","title":{"rendered":"3 Active Ingredients and Custom Manufacturing Company, Excipients and Nutrition Ingredients Maker and Portable Molecular Testing Firm Stocks With a Strong Future Roadmap: Neuland Laboratories, Sudeep Pharma and Molbio Diagnostics"},"content":{"rendered":"

Neuland Laboratories, Sudeep Pharma and Molbio Diagnostics: ROE of 14.2% to 19.6% and FY22 to FY26 revenue CAGR of 16.8% to 21.1%. Prices as of 23 Oct 2026.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

The three API, excipient and Truenat diagnostics stocks to watch are Neuland Laboratories, Sudeep Pharma and Molbio Diagnostics. Their return on equity ranges from 14.2% to 19.6%, and their revenue compound annual growth from FY22 to FY26 ranges from 16.8% to 21.1%. Sudeep Pharma has the highest return on equity at 19.6%, while Neuland Laboratories has the fastest revenue growth at 21.1% a year. Prices are based on the 23 October 2026 close, and this article is educational, not investment advice.<\/p>\n<\/div>\n

API, excipient and Truenat diagnostics stocks give investors a way to track businesses that sit close to everyday demand in India. Neuland Laboratories, Sudeep Pharma and Molbio Diagnostics cover an active ingredients and custom manufacturing company, an excipients and nutrition ingredients maker and a portable molecular testing firm.<\/p>\n

This list covers three API, excipient and Truenat diagnostics stocks with complete current figures: Neuland Laboratories, Sudeep Pharma and Molbio Diagnostics. Every figure comes from the latest reported financials and the 23 October 2026 market close. Companies without complete current figures were left out.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n